Long-term consequences of toxic epidermal necrolysis in children

Pediatrics

Volumn 109, Issue 1, 2002, Pages 74-78

  Sheridan, Robert L ^a   Schulz, John T ^a   Ryan, Colleen M ^b   Schnitzer, Jay J ^b   Lawlor, David ^b   Driscoll, Daniel N ^a   Donelan, Matthias B ^a   Tompkins, Ronald G ^a  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Burns; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BURN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; DISEASE COURSE; DRUG USE; ESOPHAGUS STRICTURE; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY DISEASE; MALE; MORBIDITY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN INJURY; SUPERINFECTION; SURVIVAL; TOXIC EPIDERMAL NECROLYSIS; VAGINA DISEASE; WOUND DRESSING;

ADOLESCENT; BOSTON; BURN UNITS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; EPIDERMAL NECROLYSIS, TOXIC; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFECTION; LENGTH OF STAY; MALE; NAILS, MALFORMED; SKIN DISEASES; SURVIVAL ANALYSIS;

EID: 0036141015     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.109.1.74     Document Type: Article

References (39)

1. Outbreak of toxic epidermal necrolysis associated with staphylococci
2. Toxic epidermal necrolysis
3. Toxic epidermal necrolysis (the scalded skin syndrome): A reappraisal
4. Drug-induced toxic epidermal necrolysis. I. An overview
5. Toxic epidermal necrolysis (Lyell syndrome)
6. Improved treatment of the Stevens-Johnson syndrome
7. Treatment of toxic epidermal necrolysis. Creteil's experience
8. Management of toxic epidermal necrolysis in a pediatric burn center
9. Toxic epidermal necrolysis. A step forward in treatment
10. The burn unit as a resource for the management of acute nonburn conditions in children
11. Femoral venous access is safe in burned children: An analysis of 224 catheters
12. Central venous catheter sepsis with weekly catheter change in paediatric burn patients: An analysis of 221 catheters
13. Development of a pediatric burn pain and anxiety management program
14. Toxic epidermal necrolysis
15. The role of extracellular products of phage group 2 staphylococci in toxic epidermal necrolysis
16. Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus
17. Haemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis, Ritter's disease and impetigo contagiosa
18. Management of acquired bullous skin diseases
19. Impaired antigen presentation in toxic epidermal necrolysis
20. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
21. Treatment of Stevens-Johnson syndrome with pooled human intravenous immune globulin
22. Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy
23. Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?
24. Toxic epidermal necrolysis (Lyell syndrome): More than acute skin failure
25. Pulmonary complications in toxic epidermal necrolysis: A prospective clinical study
26. Laryngeal involvement in toxic epidermal necrolysis
27. Acute and chronic respiratory complications of toxic epidermal necrolysis
28. Toxic epidermal necrolysis with adult respiratory distress syndrome
29. Toxic epidermal necrolysis with tracheobronchial and pulmonary complications
30. Bronchopulmonary distress associated with toxic epidermal necrolysis
31. Ileal involvement in toxic epidermal necrolysis (Lyell syndrome)
32. Toxic epidermal necrolysis - An unusual cause of colonic perforation. Report of a case
33. Vulvovaginal sequelae in toxic epidermal necrolysis
34. The ocular complications of erythema multiforme (Stevens Johnson syndrome) and their management
35. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum
36. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS
37. Long-term corneal involvement following drug-induced toxic epidermal necrolysis (Lyell's disease)
38. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
39. Silicone gel treatment of extensive hypertrophic scarring following toxic epidermal necrolysis